175 related articles for article (PubMed ID: 36136066)
1. Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity?
Churilov LP; Normatov MG; Utekhin VJ
Pathophysiology; 2022 Aug; 29(3):486-494. PubMed ID: 36136066
[TBL] [Abstract][Full Text] [Related]
2. Post-COVID Endocrine Disorders: Putative Role of Molecular Mimicry and Some Pathomorphological Correlates.
Normatov MG; Karev VE; Kolobov AV; Mayevskaya VA; Ryabkova VA; Utekhin VJ; Churilov LP
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766627
[TBL] [Abstract][Full Text] [Related]
3. Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity.
Adiguzel Y; Mahroum N; Muller S; Blank M; Halpert G; Shoenfeld Y
Clin Rev Allergy Immunol; 2023 Aug; 65(2):206-230. PubMed ID: 37505416
[TBL] [Abstract][Full Text] [Related]
4. Molecular mimicry between SARS-CoV-2 and the female reproductive system.
Dotan A; Kanduc D; Muller S; Makatsariya A; Shoenfeld Y
Am J Reprod Immunol; 2021 Dec; 86(6):e13494. PubMed ID: 34407240
[TBL] [Abstract][Full Text] [Related]
5. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.
Marino Gammazza A; Légaré S; Lo Bosco G; Fucarino A; Angileri F; Conway de Macario E; Macario AJ; Cappello F
Cell Stress Chaperones; 2020 Sep; 25(5):737-741. PubMed ID: 32754823
[TBL] [Abstract][Full Text] [Related]
6. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins.
Nunez-Castilla J; Stebliankin V; Baral P; Balbin CA; Sobhan M; Cickovski T; Mondal AM; Narasimhan G; Chapagain P; Mathee K; Siltberg-Liberles J
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891400
[TBL] [Abstract][Full Text] [Related]
7. From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry.
Kanduc D
Antibodies (Basel); 2021 Sep; 10(4):. PubMed ID: 34698069
[TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
Vahabi M; Ghazanfari T; Sepehrnia S
Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
[TBL] [Abstract][Full Text] [Related]
9. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
Mohkhedkar M; Venigalla SSK; Janakiraman V
Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
[TBL] [Abstract][Full Text] [Related]
10. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
Vojdani A; Vojdani E; Kharrazian D
Front Immunol; 2020; 11():617089. PubMed ID: 33584709
[TBL] [Abstract][Full Text] [Related]
11. Exposure to SARS-CoV-2 and Infantile Diseases.
Kanduc D
Glob Med Genet; 2023 Jun; 10(2):72-78. PubMed ID: 37144240
[No Abstract] [Full Text] [Related]
12. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
Kasperkiewicz M
Cell Stress Chaperones; 2021 Jan; 26(1):1-2. PubMed ID: 33196989
[TBL] [Abstract][Full Text] [Related]
13. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.
Kanduc D
Antibodies (Basel); 2020 Jul; 9(3):. PubMed ID: 32708525
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity against Nucleus Ambiguous Is Putatively Possible in Both Long-COVID-19 and Vaccinated Subjects: Scientific Evidence and Working Hypothesis.
D'Anna SE; Vitale AM; D'Amico G; Caruso Bavisotto C; Ambrosino P; Cappello F; Maniscalco M; Marino Gammazza A
Biology (Basel); 2024 May; 13(6):. PubMed ID: 38927239
[TBL] [Abstract][Full Text] [Related]
15. From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity.
Kanduc D
Glob Med Genet; 2021 Dec; 8(4):176-182. PubMed ID: 34877576
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
Karami Fath M; Jahangiri A; Ganji M; Sefid F; Payandeh Z; Hashemi ZS; Pourzardosht N; Hessami A; Mard-Soltani M; Zakeri A; Rahbar MR; Khalili S
Front Immunol; 2021; 12():705772. PubMed ID: 34447375
[TBL] [Abstract][Full Text] [Related]
18. Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis.
Czaja AJ
Dig Dis Sci; 2023 Jul; 68(7):2824-2842. PubMed ID: 37160542
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 and human retroelements: a case for molecular mimicry?
Koch BF
BMC Genom Data; 2022 Apr; 23(1):27. PubMed ID: 35395708
[TBL] [Abstract][Full Text] [Related]
20. Molecular mimicry and autoimmunity in the time of COVID-19.
Rojas M; Herrán M; Ramírez-Santana C; Leung PSC; Anaya JM; Ridgway WM; Gershwin ME
J Autoimmun; 2023 Sep; 139():103070. PubMed ID: 37390745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]